SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavax is trending after announcing a non-exclusive license agreement with Pfizer for its Matrix-M adjuvant, providing significant validation for the technology. This deal, building on previous collaborations, is driving community excitement and fueling discussions about the adjuvant's potential applications and the company's future partnerships amidst notable short interest.

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is driving significant conversation as escalating US-EU trade tensions, particularly over Greenland and proposed tariffs, spark widespread market uncertainty and a risk-off shift. The community is sharply divided, with intense debate over whether current volatility signals a deeper correction or presents a key buying opportunity amidst ongoing institutional interest and broader macroeconomic shifts.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is generating significant buzz following positive regulatory advancements for its ANKTIVA therapy, with the FDA outlining a path to resubmission for papillary bladder cancer that requires no new clinical trials. This news, combined with recent international approvals, is fueling strong community sentiment around the potential for a "cancer cure" and intense discussions anticipating a substantial short squeeze.

ProShares Trust - ProShares Ultra Bloomberg Natural Gas 2x Shares

ProShares Ultra Bloomberg Natural Gas

BOIL is currently experiencing a significant surge, fueled by an intense Arctic air invasion across the United States that is driving up natural gas demand and futures prices. The strong upward momentum has triggered a notable short squeeze, with the community actively discussing substantial profits and anticipating continued upside as extreme cold weather is projected to persist. This volatility is characteristic of the 2x leveraged ETF, attracting both profit-takers and those eyeing further gains.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is currently a major talking point among investors, primarily driven by its upcoming earnings report and the proposed all-cash acquisition of Warner Bros. Discovery assets, which has sparked a debate over potential growth versus debt concerns. The community is closely watching for strong ad-tier performance and subscriber metrics, particularly after a previous tax-related earnings miss, with sentiment split on whether recent oversold conditions signal a significant rebound or continued volatility.

SSgA Active Trust - SPDR S&P 500 ETF Trust

The SPY is trending as market participants react to heightened geopolitical tensions, specifically former President Trump's recent tariff threats against NATO allies over Greenland and an anticipated Supreme Court ruling on presidential tariff authority. This has sparked a fierce debate among investors, with some advocating to "buy the dip" and anticipating a rapid "Taco Trade" rebound, while others warn of a significant market correction. Adding to the volatility are concerns surrounding Japan's bond market instability, creating a complex and uncertain trading environment.

BlackRock Institutional Trust Company N.A. - iShares 20+ Year Treasury Bond ETF

iShares 20+ Year Treasury Bond ETF

TLT is experiencing significant volatility amid escalating geopolitical tensions, notably the US asserting control over Venezuela's oil and ongoing debates surrounding US tariffs, fueling a "flight to quality" narrative for some. The community is actively discussing whether these events, alongside large institutional bond purchases, will continue to boost Treasuries as a safe haven or intensify concerns over US debt and the Federal Reserve's independence.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin ($APP) is experiencing significant volatility and a notable price decline following a new short report alleging the company's involvement in money laundering. This report has sparked intense debate among investors, with many attributing the drop to market manipulation and viewing it as a buying opportunity, while others express concern over the serious accusations despite recent bullish analyst upgrades.

Corvus Pharmaceuticals, Inc. engages in the development of immune modulator product candidates with the potential to treat solid cancers, T-cell lymphomas, autoimmune diseases, and infectious diseases. Its product pipeline includes B Cell Activator and Anti-CD73, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Corvus Pharmaceuticals is trending due to overwhelmingly positive data from its Phase 1 clinical trial of soquelitinib for atopic dermatitis, with community discussions highlighting its strong efficacy in treatment-resistant patients. Investors are actively debating the potential for this novel oral ITK inhibitor to disrupt the significant atopic dermatitis market, fueling speculation of future partnerships or an acquisition and validating its broader immune-modulating platform.

ProShares Trust - ProShares UltraShort Bloomberg Natural Gas -2x Shares

ProShares UltraShort Bloomberg Natural Gas

KOLD is trending as natural gas prices sharply reverse, primarily driven by dramatically warmer weather forecasts that are erasing previous cold-snap gains. The community is actively discussing the extreme volatility and "widow maker" nature of natural gas ETFs, with many attempting to capitalize on KOLD's rapid ascent amidst widespread price uncertainty. This significant shift in winter weather expectations is compelling traders to adjust positions, leading to rapid price movements in inverse natural gas products.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

&nbsp;Posted <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.rexshares.com/2025/08/">August 11, 2025</a> In <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.rexshares.com/category/press-release/">Press Release</a>New T-REX 2X Long CRCL Daily Target ETF (CBOE: CCUP) Offers 2x Daily Exposure to Circle Internet Group, Inc. (CRCL).August 11, 2025 — REX Shares (“REX”), in partnership with Tuttle Capital Management (“Tuttle”), today announced the launch of the T-REX 2X Long CRCL Daily Target ETF (CBOE: CCUP), offering 200% daily exposure to Circle Internet Group, Inc., the company behind one of the world’s most widely used and regulated stablecoins, USDC.This launch comes at a critical moment for the digital asset ecosystem, following the passage of the GENIUS Act, which provides a clear regulatory framework for stablecoin issuance and adoption. Circle connects traditional finance and digital assets, enabling secure, 24/7 transactions and unlocking new opportunities for global commerce.“T-REX ETFs are created for traders who want targeted exposure to market leaders driving innovation,” said Scott Acheychek, COO of REX Financial. “Circle is at the heart of the shift toward a digital-first economy, and this ETF allows traders to engage directly with the company leading stablecoin adoption and digital payments.”Matt Tuttle, CEO of Tuttle Capital Management, added, “With Circle’s expanding role in enabling an institutional-grade digital payments network and the regulatory clarity brought by the GENIUS Act, we see strong demand from investors looking for tactical exposure to this next wave of financial infrastructure.”CCUP marks the latest addition to the T-REX ETF suite, which now includes over 25 leveraged and inverse single-stock ETFs providing 2x and -2x exposure to leading tech companies like Tesla, NVIDIA, Strategy, and spot crypto with Bitcoin and Ether.Investing in the Funds is not equivalent to investing directly in CRCL.For full fund information, holdings, and risk disclosures, visit <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.rexshares.com/trex">www.rexshares.com/trex</a>.About REXREX is an innovative provider of exchange-traded products specializing in alternative-strategy ETFs and ETNs, with over $7 billion in assets under management. REX is renowned for its MicroSectors™ and T-REX product lines and recently introduced a series of option-based income strategies. For more information, visit <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.rexshares.com/">rexshares.com</a>.About Tuttle Capital ManagementTuttle Capital Management is a leader in thematic and actively managed ETFs, leveraging an agile investment approach to align with market trends. Please visit <a target="_blank" rel="noopener noreferrer nofollow" href="http://www.tuttlecap.com/">www.tuttlecap.com</a> for more information.For media inquiries, please contact:Gregory FCA for REX<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:rexshares@gregoryfca.com">rexfin@gregoryfca.com</a>Matthew Tuttle for Tuttle Capital<a target="_blank" rel="noopener noreferrer nofollow" href="mailto:Mtuttle@TuttleCap.com">mtuttle@TuttleCap.com</a>Investors should consider the investment objectives, risk, charges, and expenses carefully before investing. For a prospectus or summary prospectus with this and other information about the T-REX ETFs please call 1-844-802-4004 or visit our website at <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.rexshares.com/">rexshares.com.</a> Read the prospectus and summary prospectus carefully before investing.There is no guarantee that the Funds will achieve their investment objectives. Investing involves risk, including possible loss of principal.Important RisksInvesting in a REX Shares ETF may be more volatile than investing in broadly diversified funds. The use of leverage by a Fund increases the risk to the Fund. The REX Shares ETFs are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk, consequences of seeking daily leveraged, or daily inverse leveraged, investment results and intend to actively monitor and manage their investment.An investment in the Fund entails risk. The Fund may not achieve its leveraged investment objective and there is a risk that you could lose all of your money invested in the Fund. The Fund is not a complete investment program. In addition, the Fund presents risks not traditionally associated with other mutual funds and ETFs. It is important that investors closely review all of the risks listed below and understand them before making an investment in the Fund.Leverage Risk. The Funds obtain investment exposure in excess of its net assets by utilizing leverage and may lose more money in market conditions that are adverse to its investment objective than a fund that does not utilize leverage. An investment in these Funds is exposed to the risk that a decline in the daily performance of the underlying stock will be magnified. This means that an investment in the Fund will be reduced by an amount equal to 2% for every 1% daily decline in the underlying, not including the costs of financing leverage and other operating expenses, which would further reduce its value.Distributor: Foreside Fund Services, LLC, member FINRA, not affiliated with REX Shares or the Funds’ investment advisor.<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.rexshares.com/tag/ccup/">CCUP</a>, <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.rexshares.com/tag/t-rex-leveraged-etfs/">T-REX Leveraged ETFs</a>Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

T-REX Single-Stock ETF Suite Expands to Include 2X Leveraged Exposure to Circle

https://www.rexshares.com/t-rex-single-stock-etf-suite-expands-to-include-2x-leveraged-exposure-to-circle/

CCUP
T-REX 2X Long CRCL Daily Target ETF

Feed

News

Sentiment

Fundamentals

Info

Latest CCUP News

CCUPT-REX 2X Long CRCL Daily Target ETF